LV13000B - Venlafaxine and its analogues for inducing cognition enhancement - Google Patents

Venlafaxine and its analogues for inducing cognition enhancement Download PDF

Info

Publication number
LV13000B
LV13000B LVP-03-34A LV030034A LV13000B LV 13000 B LV13000 B LV 13000B LV 030034 A LV030034 A LV 030034A LV 13000 B LV13000 B LV 13000B
Authority
LV
Latvia
Prior art keywords
carbon atoms
alkyl
use according
hydrogen
compound
Prior art date
Application number
LVP-03-34A
Other languages
English (en)
Latvian (lv)
Inventor
George Edward Morris Husbands
Magid Abdel-Megid Abou-Gharbia
John Allen Moyer
Eric Anthony Muth
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of LV13000B publication Critical patent/LV13000B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Traffic Control Systems (AREA)
LVP-03-34A 1994-02-14 2003-03-17 Venlafaxine and its analogues for inducing cognition enhancement LV13000B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19541794A 1994-02-14 1994-02-14

Publications (1)

Publication Number Publication Date
LV13000B true LV13000B (en) 2003-07-20

Family

ID=22721346

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-03-34A LV13000B (en) 1994-02-14 2003-03-17 Venlafaxine and its analogues for inducing cognition enhancement

Country Status (11)

Country Link
EP (2) EP1245228A3 (es)
JP (1) JPH07252143A (es)
AT (1) ATE229328T1 (es)
CA (1) CA2141774A1 (es)
CY (1) CY2321B1 (es)
DE (1) DE69529109T2 (es)
DK (1) DK0667150T3 (es)
ES (1) ES2185683T3 (es)
LV (1) LV13000B (es)
PT (1) PT667150E (es)
SG (1) SG49680A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
EP1905757A1 (en) * 1999-04-06 2008-04-02 Sepracor Inc. Derivatives of Venlafaxine and methods of preparing and using the same
US6673838B2 (en) † 2001-02-12 2004-01-06 Wyeth Succinate salt of O-desmethyl-venlafaxine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
DK0639374T3 (da) * 1993-06-28 2002-05-06 American Home Prod Nye behandlingsmetoder ved anvendelse af phenethylderivater

Also Published As

Publication number Publication date
CA2141774A1 (en) 1995-08-15
EP1245228A2 (en) 2002-10-02
DK0667150T3 (da) 2003-03-31
ES2185683T3 (es) 2003-05-01
PT667150E (pt) 2003-02-28
EP0667150A1 (en) 1995-08-16
ATE229328T1 (de) 2002-12-15
EP1245228A3 (en) 2002-10-09
DE69529109D1 (de) 2003-01-23
CY2321B1 (en) 2003-11-14
EP0667150B1 (en) 2002-12-11
DE69529109T2 (de) 2003-04-30
SG49680A1 (en) 1998-06-15
JPH07252143A (ja) 1995-10-03

Similar Documents

Publication Publication Date Title
US5530013A (en) Venlafaxine in the inducement of cognition enhancement
US6287597B1 (en) Antihistaminic/decongestant compositions
LV12881B (en) NEW TREATMENT METHODS USING PHENETRIC SOLUTIONS
US6306904B1 (en) Antihistaminic/antitussive compositions
EP0840603B1 (en) Pharmaceutical composition of l-dopa ethyl ester
US6037358A (en) Decongestant/antihistaminic compositions
US6417206B1 (en) Antitussive/antihist aminic/decongestant compositions
HU225534B1 (en) Pharmaceutical compositions comprising mirtazapine and one or more selective serotonin reuptake inhibitors
CZ20024110A3 (cs) Léčivo pro léčení poruch spánku
US20040034101A1 (en) Treatment and prevention of depression secondary to pain (DSP)
AU2003232137A1 (en) Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
US5656669A (en) Restorative neuropharmacological agent for motor and speech disturbance
FR2904774A1 (fr) Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
US5519057A (en) Ibuprofen-containing medicament
LV13000B (en) Venlafaxine and its analogues for inducing cognition enhancement
WO2004089351A2 (en) Treatment of progressive neurological disorders comprising a mao inhibitor (miclobemid) and an acetylcholinesterase inhibitor (tacrin)
US20010011104A1 (en) Antihistamine compositions
US6586469B2 (en) Antihistaminic/antitussive compositions
Aminoff Basic & Clinical Pharmacology
US5270341A (en) Method of treatment or prophylaxis of depression and stress
IL122853A (en) Use of allylamines in the preparation of pharmaceutical preparations
WO2001034140A1 (en) Pharmaceutical formulation
US3772440A (en) Method for the treatment of parkinsonism and depression
CA2493490A1 (en) Treatment of depression secondary to pain (dsp)
AU690664B2 (en) Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion